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Abstract
The title compound was prepared by the reaction of 1,4,10,13-tetraoxa-7,16-diazacyclo-octadecane with 4-chloro-2-
methyl-phenoxyacetic acid in a ratio of 1:2. The structure has been proved by the data of elemental analysis, IR
spectroscopy, NMR (
1H,
13C) technique and by X-ray diffraction analysis. Intermolecular hydrogen bonds between
the azonium protons and oxygen atoms of the carboxylate groups were found. Immunoactive properties of the
title compound have been screened. The compound has the ability to suppress spontaneous and Con A-
stimulated cell proliferation in vitro and therefore can be considered as immunodepressant.
Findings
Over many years the complexes of crown ethers (CE)
with protonic acids and their metal salts attract the
attention of scientific community due to both their
peculiar molecular and stereoelectronic structure as well
as the possibility of practical application [1,2]. The CE
complexes enhance physiological activity of several che-
mical compounds. This fact is likely related to the ability
of the complexes formed to overpass cellular and hema-
toorganic barriers. In particular, specific complex-form-
ing properties of CE allow them to be used for the drug
design [2].
Recently, we have shown that tris-(2-hydroxyethyl)
ammonium salts of organylheteroacetic acids [RYCH2-
COO]
-·[NH(CH2CH2OH)]3
+,( R=A r ,H e t ;Y=O ,S ,
SO2), the cation of which has compact tricyclic atrane
(2,8,9-trihydro-prototranic) structure [3], promoting to
penetration of a matter through cellular membranes,
represent a new class of biologically active compounds
[4-9]. For example, tris(2-hydroxyethyl)ammonium salt
of 4-chloro-2-methyl-phenoxyacetic acid exhibits adap-
togenic, immunomodulating and antitumor properties.
Besides, it effectively increases the resistance of animals
to microwave electromagnetic radiation [7-9].
To search for new immunoactive congeners of this
series, we have synthesized 1,4,10,13-tetraoxa-7,16-dia-
zoniumcyclo-octadecane bis(4-chloro-2-methyl-phenox-
yacetate) 1 and studied its immunoactive properties.
Compound 1 was prepared in a yield of up to 98% by
the reaction of 1,4,10,13-tetraoxa-7,16-diazacyclo-octa-
decane (1,10-diaza-18-crown-6 ether) with 4-chloro-2-
methyl-phenoxyacetic acid in a ratio of 1:2 (Figure 1).
Compound 1 forms colorless crystals with m.p. 128°C.
The structure of 1 has been proved by the data of ele-
mental analysis, IR spectroscopy and NMR (
1H,
13C)
technique. The IR spectra of 1 show broad vibration
bands of ν(NH2
+) in the region 2800-2200 cm
-1.T h e
stretching vibration bands of the O-C-O fragments of
starting CE are high-field shifted from 1120, 1100 and
1067 to 1150-1090 cm
-1. In the IR spectrum, the bands
of symmetric and asymmetric stretching vibrations of
the carboxylate-ion are observed at 1580-1350 cm
-1.
The structure of compound 1 was established by crys-
tal structure analysis. Crystal and experimental data are
summarized in Table 1. The molecular structure with
the atom labeling scheme is given in Figure 2. The pack-
ing diagram is shown in Figure 3. Selected bond lengths
(Å), bond angles (°) as well as torsion angles (°) are
listed in Table 2.
The asymmetric unit of 1 contains a half of the dipro-
tonated 1,10-diazatetraoxa-18-crown-6 moiety and 4-
chloro-2-methylphenoxyacetate as anion. The crown
ether is centrosymmetric and the second half of the
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© 2011 Adamovich et alcation is generated by inversion. 4-Chloro-2-methylphe-
noxyacetic acid is known as herbicide. In this molecule,
the benzene ring and the oxoacetic acid side-chain are
almost coplanar (CSD-Code CMPHAA) [10]. In contrast
to this, in 1 the acetate moiety is torsioned around O1-
C7 forming a torsion angle of -79.7(2)°, whereas a tor-
sion angle of only -8.0(1)° was found in the reference
compound. Additionally, the distorsion of the exo-C1
ring angles is more pronounced 1: 115.4(1), 124.3(2)°;
CMPHAA: 115.8(12), 122.0(13)°). The molecular pack-
ing is characterized by hydrogen bonds forming a rib-
bon-like structure along the crystallographic b axis. The
geometry of the hydrogen bonds are given in Table 3.
Immunoactive properties of 1 have been screened. For
example, the ability to impact on spontaneous and mito-
gen-stimulated (Con A, Sigma, 2 mkg/ml) proliferation
of splenocytes in mice in vitro (antiproliferative proper-
ties) have been studied. It has been found that com-
pound 1 exerts a distinct influence on spontaneous and
mitogen-stimulated proliferation of splenocytes. The
ability to suppress spontaneous (up to 72%) and Con A-
stimulated (up to 99%) cell proliferation of spleen in
vitro in the dosage of 3-300 mkg/ml allows compound 1
to be considered as immunodepressant.
Experimental
IR spectra were recorded on a Varian 3100 FT- IR75
spectrophotometer. NMR spectra (ppm) were measured
on a DPX 400 instrument (400,13 MHz for 1H and
101,62 MHz for 13C) in D2O or methanol D4 at 25°C.
Reflections were collected using a STOE Imaging Plate
Diffraction System (IPDS-II) at 210 K. The structure
was solved by direct methods as implemented in the
program SHELXS-97 [11]. The refinement was carried
out using SHELXL-97 [12]. All the non-hydrogen atoms
were refined anisotropically. The hydrogen atoms were
located from the difference Fourier map and refined iso-
tropically. For the visualisation of the structure the gra-
phic programs DIAMOND [13] and ORTEP for
Windows [14] were used. CIF data: Additional file 1.
CCDC reference number: 812142.
Compound 1 was synthesized in the following man-
ner. To a solution of 4-Cl-2-CH3-C6H3OCH2COOH
(4.01 g, 0.02 mol) in MeOH (10 ml), was added
dropwise a methanol (10 ml) solution of (CE) (2.62 g,
0.01 mol). The mixture was stirred at 25°C for 12 h.
O O
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Figure 1 Synthesis of the title compound 1.
Table 1 Crystal data and details of the structure solution
and refinement
Emirical formula C15H22ClNO5
Formula weight 331.79
Temperature 210(2) K
Wavelength 0.71073 Å
Crystal system, space group Triclinic, P
Unit cell dimensions a = 7.5342(6) Å a = 97.624(7)°
b = 9.1935(8) Å b = 93.340(6)°
c = 12.8532(10) Å g = 108.945(6)°
Volume 829.73(12) Å
3
Z, Calculated density 2, 1.328 g/cm
-3
Absorption coefficient 0.252 mm
-1
F(000) 352
Crystal size 1.5 × 0.6 × 0.15 mm
Θ range for data collection 1.61 to 25.0°
Reflections collected/unique 5361/2738
Refinement method Full-matrix least-squares on F
2
Data/restraints/parameters 2738/0/288
Goodness-of-fit on F
2 1.001
R indices [I >2 s(I); 2280] R1 = 0.0423, wR2 = 0.1110
R indices (all data) R1 = 0.0495, wR2 = 0.1147
Largest diff. Peak and hole 0.413 and -0.319 eÅ
-3
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Figure 2 ORTEP plot of 1, drawn at a 50% probability level,
with atom labeling. Symmetry operation:
i2-x, 2-y, 2-z.
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Page 2 of 4The solvent was distilled in vacuum. The solid residue
was repeatedly washed with ether and dried in vacuum
to afford colorless powder (6.50 g, 98% yield), soluble in
water and alcohol. Crystals suitable for X-ray diffraction
were obtained by recrystallyzation of 1 from methanol
(20°C).
1HN M R( D 2O ) :7 . 1 1 - 6 . 6 8( m ,6 H ,C 6H3O); 4.37
(s, 4H, CH2COO); 3.63-3.56 (m, 16H, OCH2,O C H 2-
CH2O); 3.15 (t, 8H, NCH2); 2.13 (s, 6H, C6H3-CH3).
13C
NMR (D2O): 176.80 (C=O); 156.04 (C6H4O); 140.87-
111.56 (C6H3); 69.42 (OCH2); 66.99 (CH2COO); 65.29
(OCH2CH2O); 47.31 (NCH2); 15.53 (C6H3-CH3). Anal.
Calcd. for C30H44Cl2O10N2:C ,5 4 . 2 4 ;H ,6 . 6 3 ;C l ,1 0 . 6 8 ;
N, 4.22; Found: C, 54.54; H, 6.60; Cl, 10.68; N, 4.02.
Conclusions
1,4,10,13-Tetraoxa-7,16-diazoniumcyclo-octadecane bis
(4-chloro-2-methyl-phenoxyacetate) 1 has been synthe-
sized by the reaction of 1,10-diaza-18-crown-6 ether
with 4-chloro-2-methyl-phenoxyacetic acid in a ratio of
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Figure 3 Packing diagram, showing a ribbon structure along b. Symmetry operation:
ii2-x, 1-y, 2-z.
Table 3 Hydrogen bond geometry (Å, °)
D-H...A D-H H...A D...A D-H...A
N1-H1...O2
ii 0.89(2) 1.83(2) 2.698(2) 165(2)
N1-H2...O3 0.93(2) 1.81(2) 2.708(2) 161(2)
Symmetry code:
ii2-x, 1-y, 2-z
Table 2 Selected bond lengths (Å), bond angles (°), and
torsion angles (°)
C1-O1 1.369(2) C4-Cl1 1.744(2)
C2-C9 1.502(2) C7-O1 1.423(2)
C7-C8 1.523(2) C8-O2 1.237(2)
C8-O3 1.249(2) C10-O4 1.420(2)
C11-O4 1.419(2) C12-O5 1.425(2)
C13-O5 1.405(2) C14-N1 1.490(2)
C15-N1 1.500(2)
O1-C1-C6 124.33(15) O1-C1-C2 115.40(13)
O1-C7-C8 115.00(14) O2-C8-O3 126.33(16)
O2-C8-C7 119.17(14) O3-C8-O7 114.48(15)
O4-C10-C15
i 109.71(13) O4-C11-C12 108.92(15)
O5-C12-C11 108.47(15) O5-C13-C14 107.27(14)
N1-C14-C13 110.33(14) N1-C15-C10
i 113.09(14)
C14-N1-C15 115.90(13) C1-O1-C7 117.34(12)
C11-O4-C1 112.78(13) C13-O5-C12 111.91(13)
O1-C1-C2-C3 -178.46(15) O1-C1-C2-C9 -1.0(3)
C2-C3-C4-Cl1 -177.68(14) O1-C7-C8-O2 -15.4(2)
O1-C7-C8-O3 166.31(14) O4-C11-C12-O5 67.19(19)
O5-C13-C14-N1 -173.03(15) C13-C14-N1-C15 -179.80(15)
C10
i-C15-N1-C14 -72.10(19) C6-C1-O1-C7 5.5(2)
C2-C1-O1-C7 -174.16(16) C8-C7-O1-C1 -79.74(19)
C12-C11-O4-C10 -167.40(15) C15
i-C10-O4-C11 167.28(14)
C14-C13-O5-C12 -175.94(15) C11-C12-O5-C13 179.36(16)
Symmetry code:
i2-x, 2-y, 2-z
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Page 3 of 41:2 (yield 98%). The structure of 1 has been proved by
the data of elemental analysis, IR spectroscopy, NMR
(
1H,
13C) technique and X-ray diffraction analysis. X-ray
diffraction analysis has shown that the crown ether
cation is centrosymmetric. The packing is characterized
by a ribbon-like structure stabilized by hydrogen bonds.
The title compound is a representative of a novel class
of physiologically active compounds possessing immu-
nodepressant properties. The investigation of physiologi-
cal activity of 1 will be conducted in a new future.
Additional material
Additional file 1: Crystallographic information. Contains all relevant
CIF information.
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